Not Losing Weight on Semaglutide or Tirzepatide?
If you’re not losing weight on semaglutide, you’re not alone. Many patients see early progress, then suddenly hit a plateau.
You’re eating less. You’re doing everything right.
But the scale isn’t moving.
There may be a reason—and a smarter way forward.
Start Your Provider Consult Here
Provider-guided care. No charge beyond consult if treatment is not appropriate.
Does this sounds familiar?
- You started semaglutide or tirzepatide and saw initial results
- Now your weight loss has slowed—or stopped completely
- You’re frustrated because nothing else has changed
- You’re wondering if the medication has “stopped working”
This is one of the most common challenges patients face with GLP-1 medications—and it’s often misunderstood.
Why weight loss can plateau on GLP-1 medications
Weight loss is not just about appetite. Several factors can affect progress:
- Metabolic adaptation – your body adjusts to lower calorie intake
- Loss of lean muscle mass – which can slow metabolism
- Hormonal and stress responses – impacting fat loss
- Inflammation and recovery limitations
- Medication alone may not address the full metabolic picture
TEXT:
Increasing your dose isn’t always the answer. In many cases, the issue is how your body is responding—not just the medication itself.
A more complete, provider-guided approach
At Bridgeside Telehealth, we take a broader view of metabolic health.
Instead of focusing only on GLP-1 medications, we evaluate:
- Metabolic function
- Recovery and inflammation
- Muscle preservation
- Overall treatment response
In appropriate patients, this may include targeted peptide support alongside GLP-1 therapy to help address underlying factors affecting progress.
Why weight loss can plateau on GLP-1 medications
Weight loss is not just about appetite. Several factors can affect progress:
- Metabolic adaptation – your body adjusts to lower calorie intake
- Loss of lean muscle mass – which can slow metabolism
- Hormonal and stress responses – impacting fat loss
- Inflammation and recovery limitations
- Medication alone may not address the full metabolic picture
TEXT:
Increasing your dose isn’t always the answer. In many cases, the issue is how your body is responding—not just the medication itself.
A more complete, provider-guided approach
At Bridgeside Telehealth, we take a broader view of metabolic health.
Instead of focusing only on GLP-1 medications, we evaluate:
- Metabolic function
- Recovery and inflammation
- Muscle preservation
- Overall treatment response
SUBTEXT:
In appropriate patients, this may include targeted peptide support alongside GLP-1 therapy to help address underlying factors affecting progress.
What a personalized plan may include
Depending on your evaluation:
- Adjustment of your current GLP-1 protocol
- Support for muscle preservation and recovery
- Metabolic support strategies
- Provider-guided peptide options (if appropriate)
All treatments are determined by a licensed provider based on your medical history and clinical evaluation.
GLP-1 Optimization Review
- Comprehensive provider review
- Personalized treatment recommendations
- Clear next steps based on your goals
PRICE:
$99 consult — applied toward treatment if prescribed
ADD:
No charge beyond the consult if treatment is not appropriate.
CTA BUTTON:
FAQ:
Why did my weight loss stop?
Weight loss plateaus are common and may be related to metabolic adaptation, muscle loss, or other physiological factors.
Do I need to increase my dose?
Not always. Increasing dose does not address all underlying causes of a plateau.
Do you prescribe peptides?
If clinically appropriate, providers may include peptide therapy as part of a broader treatment plan.
Is this covered by insurance?
Most services are self-pay. We can provide documentation for patients pursuing reimbursement.
What happens after I schedule?
You’ll complete a brief intake, undergo provider review, and receive personalized recommendations.
Don’t stay stuck. Get clarity on what’s really happening.
A provider-guided review can help you understand your plateau and identify the next step forward.
CTA BUTTON:
Medications prescribed through Bridgeside Telehealth are compounded formulations based on individual provider evaluation. These medications are not FDA-approved for specific indications. Results may vary. Risks, benefits, and alternatives are discussed prior to treatment.
